Athyrium Opportunities II Co-Invest 1 LP - Net Worth and Insider Trading

Athyrium Opportunities II Co-Invest 1 LP Net Worth

The estimated net worth of Athyrium Opportunities II Co-Invest 1 LP is at least $10 Million dollars as of 2024-09-23. Athyrium Opportunities II Co-Invest 1 LP is the 10% Security Holder of HLS Therapeutics Inc and owns about 3,051,782 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $10 Million. Details can be seen in Athyrium Opportunities II Co-Invest 1 LP's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Athyrium Opportunities II Co-Invest 1 LP has not made any transactions after 2023-06-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Athyrium Opportunities II Co-Invest 1 LP

To

Athyrium Opportunities II Co-Invest 1 LP Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities II Co-Invest 1 LP owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .

Click here to see the complete history of Athyrium Opportunities II Co-Invest 1 LP’s form 4 insider trades.

Insider Ownership Summary of Athyrium Opportunities II Co-Invest 1 LP

Ticker Comapny Transaction Date Type of Owner
TSX:HLS HLS Therapeutics Inc 2023-06-30 10% Security Holder

Athyrium Opportunities II Co-Invest 1 LP Latest Holdings Summary

Athyrium Opportunities II Co-Invest 1 LP currently owns a total of 1 stock. Athyrium Opportunities II Co-Invest 1 LP owns 3,051,782 shares of HLS Therapeutics Inc (TSX:HLS) as of June 30, 2023, with a value of $10 Million.

Latest Holdings of Athyrium Opportunities II Co-Invest 1 LP

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:HLS HLS Therapeutics Inc 2023-06-30 3,051,782 3.20 9,765,702

Holding Weightings of Athyrium Opportunities II Co-Invest 1 LP


Athyrium Opportunities II Co-Invest 1 LP Form 4 Trading Tracker

According to the SEC Form 4 filings, Athyrium Opportunities II Co-Invest 1 LP has made a total of 1 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in HLS Therapeutics Inc is the sale of 1,300,000 shares on June 30, 2023, which brought Athyrium Opportunities II Co-Invest 1 LP around $8 Million.

Insider Trading History of Athyrium Opportunities II Co-Invest 1 LP

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Athyrium Opportunities II Co-Invest 1 LP Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Athyrium Opportunities II Co-Invest 1 LP Ownership Network

Ownership Network List of Athyrium Opportunities II Co-Invest 1 LP

No Data

Ownership Network Relation of Athyrium Opportunities II Co-Invest 1 LP

Insider Network Chart

Athyrium Opportunities II Co-Invest 1 LP Owned Company Details

What does HLS Therapeutics Inc do?

Who are the key executives at HLS Therapeutics Inc?

Athyrium Opportunities II Co-Invest 1 LP is the 10% Security Holder of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , Senior Officer Brian Thomas Walsh , and 10% Security Holder Polar Asset Management Partners Inc. .

HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary

Over the past 18 months, Athyrium Opportunities II Co-Invest 1 LP made 1 insider transaction in HLS Therapeutics Inc (TSX:HLS) with a net sale of 1,300,000. Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 12,500 shares made by Craig Millian , and a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. .

In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.

HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HLS Therapeutics Inc Insider Transactions

No Available Data

Athyrium Opportunities II Co-Invest 1 LP Mailing Address

Above is the net worth, insider trading, and ownership report for Athyrium Opportunities II Co-Invest 1 LP. Currently GuruFocus does not have mailing address information for Athyrium Opportunities II Co-Invest 1 LP.

Discussions on Athyrium Opportunities II Co-Invest 1 LP

No discussions yet.